Haining Zhou
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Diagnosis and Treatment 7
- Lung Cancer Treatments and Mutations 5
- Gastric Cancer Management and Outcomes 4
-
- RNA modifications and cancer 6
- Co-authors
- Shoujun Tang (10 shared papers)A. van Oosterom (3 shared papers)Shengjie Tang (8 shared papers)Haiyang Hu (6 shared papers)Hang Yan (5 shared papers)Chao Qin (4 shared papers)Jianning Yao (8 shared papers)Xuexiu Zhang (7 shared papers)
- Journals
- Cells (2 papers)Medicine (2 papers)BMC Cancer (2 papers)Journal of Clinical Oncology (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaJapanSwitzerland
In The Last Decade
Haining Zhou
44 papers receiving 753 citations
Haining Zhou's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 207
- Oncology 223
- Pulmonary and Respiratory Medicine 193
- Molecular Biology 300
- Surgery 167
Countries citing papers authored by Haining Zhou
This map shows the geographic impact of Haining Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haining Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haining Zhou more than expected).
Fields of papers citing papers by Haining Zhou
This network shows the impact of papers produced by Haining Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haining Zhou. The network helps show where Haining Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Haining Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Progress, Challenges, and Prospects Hit paper breakdown → | 2022 | 128 |
| 2 | 2019 | 75 | |
| 3 | 2012 | 69 | |
| 4 | 2022 | 53 | |
| 5 | 1992 | 49 | |
| 6 | 2018 | 48 | |
| 7 | 2021 | 44 | |
| 8 | 2021 | 35 | |
| 9 | 2019 | 29 | |
| 10 | 2018 | 27 | |
| 11 | 2021 | 21 | |
| 12 | 2022 | 17 | |
| 13 | 2020 | 17 | |
| 14 | 2018 | 15 | |
| 15 | 2021 | 13 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 11 | |
| 18 | 2020 | 11 | |
| 19 | 2017 | 10 | |
| 20 | 2017 | 10 |
About Haining Zhou
Haining Zhou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Oncology and Cancer Research, having authored 52 papers that have together received 767 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), RNA modifications and cancer (6 papers), MicroRNA in disease regulation (6 papers), Esophageal Cancer Research and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Lung Cancer Research Studies (4 papers). The work is most often cited by research in Cancer Research (207 citations), Oncology (223 citations), Pulmonary and Respiratory Medicine (193 citations), Molecular Biology (300 citations) and Surgery (167 citations). Haining Zhou has collaborated with scholars based in China, Japan and Switzerland. Frequent co-authors include Shoujun Tang, A. van Oosterom, Shengjie Tang, Haiyang Hu, Hang Yan, Chao Qin, Jianning Yao, Xuexiu Zhang, Jun Zhang and Tao Liu. Their work appears in journals such as Cells, Medicine, BMC Cancer, Journal of Clinical Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.